In a few patients, mutations in other genes, such as WT1 and IDH2, were also found in the corresponding CP samples with lower tumour cell fractions (TCFs) calculated by variant allele frequencies (VAFs) than those found in the BC samples (Supplementary Fig. 1f). This evidence concerns the gene WT1 and breast cancer.